Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

Natural health products and traditional medicines are the vital components in the discovery and the development of drugs for the treatment of human diseases. Natural products including dozens of spices and plant extracts have been utilized by the traditional medicines in the Native American, Chinese, and Indian cultures which has shown that many do indeed have potent anticancer effects according to Scientific research.

An extract from the Mayapple, Podophyllum peltatum, Curcumin, Camptothecin, Turmeric (Curcuma longa). Likewise, numerous natural products used in traditional Indian Ayurvedic medicine have been shown to have strong anti-inflammatory and anticancer properties.

A total of 27 anticancer drugs from 1940 to 2010 were obtained from natural sources, for instance actinomycin D, paclitaxel, and vincristine, now one of the most commonly used chemotherapy agents in cancer treatment, while topotecan HCl, dexamethasone, etoposide, and even tamoxifen are mimics of natural products.

  • Track 1-1Ayurvedic medicine
  • Track 1-2Complementary and alternative medicine
  • Track 1-3Herbal and Traditional Medicine
  • Track 1-4Quality control and standardization of drug
  • Track 1-5Phytomedicine
  • Track 1-6Chinese Medicine

Nanotechnology in Cancer Treatments is used to treat Cancer tumours with minimal damage to healthy tissues and organs. This technique is also used to detect and eliminate cancer cells before they form tumours.

A targeted chemotherapy treatment under development uses a nanoparticle called CRLX101. Another technique being developed works on destroying cancer tumours by applying heat.

Targeted heat therapy is being developed to destroy breast cancer tumours. Another method that targets individual cancer cells inserts gold nanoparticles into the cells, then shines a laser on the nanoparticles. The heat explodes the cancer cells.

  • Track 2-1Biostatistics
  • Track 2-2Clinical genetics and genomics
  • Track 2-3Epidemiology
  • Track 2-4Nano-enabled Immunotherapy
  • Track 2-5Nanomedicine
  • Track 2-6Nano materials for cancer diagnosis and therapy
  • Track 2-7RNA Nanotechnology for Cancer treatment

Cancer Biology deals with the study of cell growth and its transformation to cancer cells from which many innovative and new clinical technologies are invented. The molecular mechanisms and the cell signalling pathways of cancer cell development are currently being studied by expert researchers.

An enormous spectrum of diseases that all originate from uncontrolled cellular growth which are widely divided into benign tumours or malignant tumours, cancers are further defined and classified by their cell type, tissue, or organ of origin.


  • Track 3-1Molecular Biology
  • Track 3-2Cell Biology
  • Track 3-3Carcinogenesis
  • Track 3-4Immunology
  • Track 3-5Biostatistics
  • Track 3-6Clinical genetics and genomics
  • Track 3-7Epidemiology

Cancer is a complex disease that impacts every patient differently. Comprehensive and personalized treatment starts with an accurate, thorough diagnosis.

Cancer screening tests are tests that look for the presence of cancer in healthy people or people without symptoms of cancer. Cancer screening tests are designed to find cancers at an early stage when they are more treatable.  

  • Track 4-1Mammography
  • Track 4-2Human papillomavirus (HPV) testing
  • Track 4-3Colonoscopy
  • Track 4-4Dermoscopy

Cancer Immunology is the artificial stimulation of the immune system to treat cancer which thereby improves the immune system’s naturally ability to fight cancer.

Some of the immunotherapy treatments that don’t target cancer cells directly but boost the immune system to make it more effective against cancer. Examples of these treatments and the cancers they help include: Bacille Calmette-Guérin -- early-stage bladder cancer, Imiquimod (Zyclara) -- early-stage skin cancer.


  • Track 5-1Carcinogenesis
  • Track 5-2Onco-genomics
  • Track 5-3Cancer Immunology & Immunotherapy
  • Track 5-4Cancer therapeutic resistance

Research efforts in cancer pharmacology include studies of the basic mechanisms of signal transduction associated with cell proliferation and apoptosis, the mechanisms of action of anti-neoplastic agents, the design and discovery of new drugs, basic mechanisms of DNA repair and DNA damage tolerance and the development of novel strategies for gene therapy.


  • Track 6-1Biomedical Engineering
  • Track 6-2Cell/Developmental Biology and Molecular Genetics
  • Track 6-3Regenerative Medicine - Curative Therapeutics
  • Track 6-4Regenerative Pharmacology

Chemotherapy is the chemical drug therapy which is used to treat cancer. This treatment is used to destroy the rapidly growing cells in the body. It is usually used to treat cancer, as cancer cells grow and divide faster than other cells.

Chemotherapy is often used in combination with other therapies, such as surgery, radiation, or hormone therapy.  This depends on the stage and type of cancer you have, your overall health, previous cancer treatments you’ve had, the location of the cancer cells, your personal treatment preferences.


  • Track 7-1Alkylating Agents
  • Track 7-2Plant Alkaloids
  • Track 7-3Antitumor Antibiotics
  • Track 7-4Antimetabolites
  • Track 7-5Topoisomerase Inhibitors
  • Track 7-6Miscellaneous Antineoplastics

Clinical trials for cancer are research studies that compare the most effective known treatment for a specific type or stage of cancer with a new approach. This can be a new drug, or combination of drugs or a different way of using established therapies.

There are trials that involve new approaches to surgery and radiation therapy. There are clinical trials for every type of cancer. While many trials focus on late stage disease, there are also trials to prevent cancer, improve early diagnosis, stop the cancer from coming back, reduce side effects or improve quality of life.


  • Track 8-1Clinical trials collaboration
  • Track 8-2Artificial Intelligence in Clinical research
  • Track 8-3Follow up and close out phase in clinical trials
  • Track 8-4Data types and data processing techniques
  • Track 8-5Integrated technology platforms
  • Track 8-6Tissue Biomarkers

Cancer Treatment is majorly constituted by Immunotherapy in improving the prognosis of many patients with a wide variety of haematological and solid malignancies which are driven by the two main key agents known as checkpoint inhibitors (CPIs) and chimeric antigen receptor (CAR) T cells.


  • Track 9-1Combination with immunomodulatory drugs
  • Track 9-2New Tumour entities
  • Track 9-3Tissue Biomarkers
  • Track 9-4Inflammatory gene signatures

Neonatal cancer consists of heterogeneous group of neoplasms with substantial histological diversity. Neonatology is a subspecialty of paediatrics that deals with the medical care of new-born infants, especially the premature or ill new-born. Almost all types of paediatric cancer can occur in foetuses and neonates; however, the presentation and behaviour of neonatal tumours often differs from that in older children, leading to differences in diagnosis and management.


  • Track 10-1Neonatal Haematology Oncology
  • Track 10-2Neonatal Leukemia
  • Track 10-3Neuroblastoma in Children
  • Track 10-4Advanced Neonatal Oncology Drugs
  • Track 10-5Neonatal Oncology Diagnosis
  • Track 10-6Neonatal Neuro Oncology
  • Track 10-7Brain Tumour in Children
  • Track 10-8Advances in Neonatal Oncology Treatment
  • Track 10-9Oncology Nursing and Care
  • Track 10-10Palliative care
  • Track 10-11Treatment

Oncology nursing is a field where special care is given for the patients by highly trained oncology nurses. Highly qualified and experienced nurses take good care of the patients practicing safe screening techniques and preventive steps.        


  • Track 11-1Pediatric nursing
  • Track 11-2Palliative care
  • Track 11-3Education
  • Track 11-4Treatment

There are different types of cancers based on location of cancer in the body organ. Targeting cancer metabolism has the potential to lead to major advances in tumour therapy. Numerous promising metabolic drug targets have been identified.


  • Track 12-1Brain cancer
  • Track 12-2Head and Neck cancer
  • Track 12-3Oral cancer
  • Track 12-4Lung cancer
  • Track 12-5Liver cancer
  • Track 12-6Breast cancer
  • Track 12-7Prostate cancer
  • Track 12-8Gastric cancer
  • Track 12-9Pancreatic cancer
  • Track 12-10Kidney (Renal Cell) cancer
  • Track 12-11Leukemia

Precision medicine for cancer is an approach to deliver the most appropriate treatments based on the characteristics of your cancer


  • Track 13-1Physiology & Cancer History
  • Track 13-2Identifying Risk Factors
  • Track 13-3Cancer Genomics & Biologic Factors
  • Track 13-4Targeted Agents & Conventional Treatment
  • Track 13-5New Genotyping Technologies

Cancer prevention includes the implementation of safety measures which helps to reduce or prevent the risk of getting cancer. This action has been purposefully implemented because it makes the individual to lead a healthy and safety life. Lifestyle, exposure and other factors may influence the risk of cancer.

Cancer is to a large extent avoidable. Many cancers can be prevented. Others can be detected early in their development, treated and cured. Even with late stage cancer, the pain can be reduced, the progression of the cancer slowed, and patients and their families helped to cope.


  • Track 14-1Cancer Prevention
  • Track 14-2Cancer Control
  • Track 14-3Cancer Epidemiology
  • Track 14-4Palliative care

The usage of high-energy radiation to treat cancer in which the ability of cancer cells to reproduce are destroyed and the body naturally get rid of these cells. Radiation therapy given by radioactive sources that are put inside the patient is called brachytherapy

Other techniques that enable ultra-precise doses of radiation to tumours include stereotactic radiosurgery, which uses 3-D imaging to determine the exact coordinates of a tumour. The highly focused gamma rays or x-rays then converge on the tumour to treat it.


  • Track 15-1Radiation simulation
  • Track 15-2Planning scans
  • Track 15-3Results
  • Track 15-4Clinical trials

The goal of regenerative medicine can be concisely codified as the repair and/or replacement of damaged cells, tissues, and organs for functional restoration. It is a global, interdisciplinary effort with a translational research focus on development of therapies for patients afflicted with a variety of age - and disease-related disorders/dysfunction.


  • Track 16-1Advancing Cancer Treatment
  • Track 16-2Cancer Research and Medicine

Surgery for cancer treatments helps in preventing many types of cancer, and it also plays a part in diagnosing, staging, and supporting cancer treatment.

Historically, surgery was the only treatment for cancer with pioneering surgeons pushing the boundaries of knowledge down through the millennia. Surgery is the modality with the potential to cure most solid cancers. Surgeons have a pivotal role in cancer treatments and research, leading the diagnostic and treatment pathways for most cancers from counselling patients about their diagnosis through to surgery and aftercare. They have also led many of the great advances in cancer research.


  • Track 17-1Breast cancer surgery
  • Track 17-2Colorectal cancer surgery
  • Track 17-3Cranial base surgery
  • Track 17-4Laparoscopic lymphadenectomy
  • Track 17-5Side effects

Cancer Science deals with the study of cancer cells causing tumours and the therapy is processed technically. The Cancer specific genes, proteins, or the tissue environment that contribute to cancer growth and survival are targeted by targeted therapy. It can be inferred from several studies that not all tumours have the same targets which reveals that same targeted treatment will not work for everyone.

For example, a gene called KRAS controls the growth and spread of a tumour. This gene mutation has been impacted with about 40% of colorectal cancers.


  • Track 18-1Cell Signalling
  • Track 18-2Types of targeted therapies
  • Track 18-3Management
  • Track 18-4Clinical trials
  • Track 18-5Limitations

Translational Oncology forms the bridge between basic research and clinical practice thereby holding the key to the progress in oncology. Tumour heterogeneity, Liquid biopsies, and Immunotherapy play a vital role in Translational Oncology.


  • Track 19-1Cellular and genetic oncology
  • Track 19-2Laboratory concepts from bench to bedside
  • Track 19-3Cancer microenvironment
  • Track 19-4Cancer trends and Opportunities
  • Track 19-5Radiation Oncology
  • Track 19-6World Cancer Market